Motegrity (prucalopride) is a prescription drug that’s used to treat chronic idiopathic constipation. Motegrity can cause side effects that range from mild to serious. Examples include headache and ...

Motegrity (prucalopride) is a brand-name drug that’s prescribed for chronic idiopathic constipation in adults. Motegrity comes as a tablet that’s typically taken once per day. Motegrity belongs to a ...

Motegrity (prucalopride) is a prescription drug that’s used to treat chronic idiopathic constipation in adults. Motegrity’s cost may depend on factors such as your dosage, whether you have health ...

Shire has the US approval it needs for Motegrity, a drug for chronic idiopathic constipation (CIC) that will compete with drugs like Allergan’s Linzess and Synergy’s Trulance. The FDA’s backing was ...

Shire announced that the Food and Drug Administration (FDA) has approved Motegrity (prucalopride) tablets for the treatment of adults with chronic idiopathic constipation (CIC). The FDA approval was ...

Prucalopride, a serotonin-4 receptor agonist, is indicated for the treatment of chronic idiopathic constipation in adults. The first generic version of Motegrity ® has been approved by the Food and ...

Please provide your email address to receive an email when new articles are posted on . Motegrity, a once-daily, oral selective serotonin-4 receptor agonist, is now available via prescription in the U ...

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP), a biopharmaceutical company, on Thursday announced that the U.S. Food and Drug Administration has approved its Abbreviated New Drug Application for ...

Takeda is set to gulp up Shire, whether disgruntled investors like the deal or not. But for those in the latter camp, the biotech’s latest approval may make it easier to swallow. The company has ...

ANI is offering prucalopride tablets, which is the generic of Takeda's Motegrity. Motegrity is used in adults to treat chronic idiopathic constipation. "We are delighted to build momentum early in ...

(RTTNews) - Shire plc (SHP.L, SHPG) announced the U.S. FDA has approved Motegrity, a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation. Motegrity is expected to launch ...

Motegrity (prucalopride) is a brand-name tablet that’s prescribed for chronic idiopathic constipation (CIC) in adults. As with other drugs, Motegrity can cause side effects, such as nausea, diarrhea, ...